Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ancient grain, modern hope: foxtail millet muffins may tame blood sugar in obesity

NCT ID NCT07699250

Disease control Sponsor: University of Lahore Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study investigates whether adding foxtail millet muffins to the diet can help manage blood sugar and improve metabolic health in obese adults with type 2 diabetes. Over 10 weeks, participants eat either a wheat muffin or one or two foxtail millet muffins daily, alongside a low glycemic index diet. Researchers track changes in weight, blood sugar, cholesterol, and liver function to see if this simple dietary swap makes a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Foxtail millet muffin
What this could lead to
If effective, this dietary approach could offer a simple, affordable way for obese diabetic patients to improve blood sugar control and reduce heart disease risk.
What could go wrong
This is a small, short-term dietary study. Results may not apply to all diabetics, and long-term benefits or risks are unknown. Dietary changes alone may not be enough for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

102 people

The number who actually took part.

Started

Apr 2025

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria:i. Inclusion Criteria * People between 30 to 60 years old * Body Mass Index (BMI) ≥30.0 kg/m² * Fasting blood glucose levels ≥ 7.0 mmol/L (126 mg/dL) * Individuals having HbA1c ≥ 6.5% * Elevated Lipid Profile: TC \> 200 mg/dL, TG \> 150 mg/dL, LDL-C \> 100 mg/dL, HDL-C \< 40 mg/dL (men) / \< 50 mg/dL (women) * Elevated Liver Function Tests: ALT \> 56 U/L, AST \> 40 U/L, ALP \> 147 U/L, Total Bilirubin \> 1.2 mg/dL, Albumin \< 3.5 g/dL ii. Exclusion Criteria * Individuals who have a known allergy or have experienced any adverse reaction to foxtail millet or any of the ingredients used in the muffins will not be included in the study * Patients who are taking medications known to significantly alter glucose metabolism or gastrointestinal absorption * Individuals who have recently had gastric surgery or who have surgery planned during the research period * Presence of other severe chronic diseases (e.g., severe renal, hepatic, or cardiovascular disease, active cancer) * Nursing or pregnant females

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diabetes mellitus liver disorder obesity disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes Lipid profiles LIVER

Contacts and locations

Locations

  • Sana Noreen

    Lahore, Punjab Province, 54000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.